Ann: Phase III prophylaxis trial for CS-8958 , page-44

So true senjo

BTA holders get it from every side.

The drugs are amazing. The rest isn't

BTA have been successful in snatching defeat from the jaws of victory.

They might not care about the share price but I do from the perpective that we will all be robbed the true value of our BTA investment by a predator.

Add the parts up. ( this is rough and Just to prove a point )

Relenza 50 million

Inavir. 231 million

Rsv 50 million

hrv 100 million

Anti bacterial. 25 million

Cash. 60 million

Flunet 50 million

Office and equipment. 10 million

Intellectual property. 10 million


So break it all up today and we have say $ 576 million. That nearly $3.00 a share. Point is the sum of our parts is currently worth more than the whole. That means takeover.